27 related articles for article (PubMed ID: 14699495)
1. ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP-1-dependent manner.
Yang JJ; Lee YJ; Hung HH; Tseng WP; Tu CC; Lee H; Wu WJ
Cancer Sci; 2010 Jun; 101(6):1374-81. PubMed ID: 20331627
[TBL] [Abstract][Full Text] [Related]
2. Correction: Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis.
Mi Y; Li Q; Liu B; Wang D; Liu Z; Wang T; Wang Y; Zang Y; Zhou Y; Wen Y; Ding Y
Gastric Cancer; 2024 May; 27(3):646-648. PubMed ID: 38519729
[No Abstract] [Full Text] [Related]
3. Reduction in MicroRNA-4488 Expression Induces NFκB Translocation in Venous Endothelial Cells Under Arterial Flow.
Fang SY; Huang CW; Huang TC; Yadav A; Chiu JJ; Wu CC
Cardiovasc Drugs Ther; 2021 Feb; 35(1):61-71. PubMed ID: 32902737
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis to identify action targets in NCI-N87 gastric cancer cells exposed to quercetin.
Zeng Y; Shen Z; Gu W; Wu M
Pharm Biol; 2018 Dec; 56(1):393-398. PubMed ID: 30266078
[TBL] [Abstract][Full Text] [Related]
5. Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis.
Chen W; Liu Q; Lv Y; Xu D; Chen W; Yu J
World J Surg Oncol; 2017 Jul; 15(1):119. PubMed ID: 28673327
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1.
Zhang C; Su ZY; Wang L; Shu L; Yang Y; Guo Y; Pung D; Bountra C; Kong AN
Biochem Pharmacol; 2016 Oct; 117():35-45. PubMed ID: 27520485
[TBL] [Abstract][Full Text] [Related]
7. Modeling of non-steroidal anti-inflammatory drug effect within signaling pathways and miRNA-regulation pathways.
Li J; Mansmann UR
PLoS One; 2013; 8(8):e72477. PubMed ID: 23967306
[TBL] [Abstract][Full Text] [Related]
8. Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: differences in mode of cyclooxygenase inhibition.
Kodela R; Chattopadhyay M; Goswami S; Gan ZY; Rao PP; Nia KV; Velázquez-Martínez CA; Kashfi K
J Pharmacol Exp Ther; 2013 Apr; 345(1):85-94. PubMed ID: 23349335
[TBL] [Abstract][Full Text] [Related]
9. Delphinidin attenuates neoplastic transformation in JB6 Cl41 mouse epidermal cells by blocking Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling.
Kang NJ; Lee KW; Kwon JY; Hwang MK; Rogozin EA; Heo YS; Bode AM; Lee HJ; Dong Z
Cancer Prev Res (Phila); 2008 Dec; 1(7):522-31. PubMed ID: 19139002
[TBL] [Abstract][Full Text] [Related]
10. Cocoa procyanidins suppress transformation by inhibiting mitogen-activated protein kinase kinase.
Kang NJ; Lee KW; Lee DE; Rogozin EA; Bode AM; Lee HJ; Dong Z
J Biol Chem; 2008 Jul; 283(30):20664-73. PubMed ID: 18519570
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins and cancer.
Wang D; Dubois RN
Gut; 2006 Jan; 55(1):115-22. PubMed ID: 16118353
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
14. NS-398 and piroxicam suppress UVB-induced activator protein 1 activity by mechanisms independent of cyclooxygenase-2.
Liu G; Ma WY; Bode AM; Zhang Y; Dong Z
J Biol Chem; 2003 Jan; 278(4):2124-30. PubMed ID: 12433932
[TBL] [Abstract][Full Text] [Related]
15. The 2 Faces of JNK Signaling in Cancer.
Tournier C
Genes Cancer; 2013 Sep; 4(9-10):397-400. PubMed ID: 24349637
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase.
Wong BC; Jiang XH; Lin MC; Tu SP; Cui JT; Jiang SH; Wong WM; Yuen MF; Lam SK; Kung HF
Gastroenterology; 2004 Jan; 126(1):136-47. PubMed ID: 14699495
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 inhibitor SC-236 [4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-l] benzenesulfonamide] suppresses nuclear factor-kappaB activation and phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and c-Jun N-terminal kinase in human mast cell line cells.
Kim SJ; Jeong HJ; Choi IY; Lee KM; Park RK; Hong SH; Kim HM
J Pharmacol Exp Ther; 2005 Jul; 314(1):27-34. PubMed ID: 15784648
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
